Comparing Lumify vs Tetrahydrozoline Ophthalmic
Lumify (brimonidine) | Tetrahydrozoline ophthalmic |
|
---|
Lumify (brimonidine) | Tetrahydrozoline ophthalmic |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Over-the-counter
Prescribed for Eye Redness. Lumify may also be used for purposes not listed in this medication guide. |
Prescription and OTC
Prescribed for Eye Redness. Tetrahydrozoline ophthalmic may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||
More about Lumify (brimonidine) | More about Tetrahydrozoline ophthalmic | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Lumify has an average rating of 3.2 out of 10 from a total of 175 ratings on Drugs.com. 19% of reviewers reported a positive effect, while 73% reported a negative effect. |
Tetrahydrozoline ophthalmic has an average rating of 9.7 out of 10 from a total of 3 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Lumify side effects |
|||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
Lower cost generic approved |
Lower cost generic |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Lumify prices |
View all Tetrahydrozoline ophthalmic prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Other brimonidine brands include: Alphagan P, Lumify Preservative Free, Qoliana | Altazine, Clarine, Eye Moisturizing Relief, Eye-Sine, Geneye Extra, Geneyes, Opti-Clear, Optigene 3, Visine Extra, Visine Maximum Redness Relief, Visine Original View more | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category N
Not classified
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 367 drugs are known to interact with Lumify:
|
A total of 49 drugs are known to interact with Tetrahydrozoline ophthalmic:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
December 22, 2017 |
N/A |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
N/A |
|||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Alphagan P
Alphagan P is used to treat glaucoma or ocular hypertension (high pressure inside the eye). Learn ...
Ubrelvy
Ubrelvy (ubrogepant) tablets are used for the acute treatment of migraine. Includes Ubrelvy side ...
Flarex
Flarex is used for eye redness, eye redness/itching, eyelash hypotrichosis
FML
FML is used for eye redness, eye redness/itching, eyelash hypotrichosis
Clear Eyes Redness Relief
Clear Eyes Redness Relief is used for eye redness
FML Liquifilm
FML Liquifilm is used for eye redness, eye redness/itching, eyelash hypotrichosis
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.